Society of Nuclear Medicine

Oncology & Cancer

Double targeting ligands to identify and treat prostate cancer

Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while protecting healthy tissue and reducing side effects. The new approach utilizes a single molecule designed ...

Immunology

PET detects neuroinflammation in multiple sclerosis

The triggers of autoimmune inflammation in multiple sclerosis (MS) have eluded scientists for many years, but molecular imaging is bringing researchers closer to identifying them, while providing a means of evaluating next-generation ...

Addiction

PET/CT reveals adaptations of the alcoholic brain

Alcoholism is a devastating disorder that too often leads to a perpetual cycle of abuse. An emerging molecular imaging technique may provide a way to break that cycle. It could signal patients' heightened risk and lead to ...

Cardiology

Optical and PET/CT probes detect early signs of atherosclerosis

Researchers at Stanford University have demonstrated for the first time the use of a dual optical and PET/CT activity-based probe to detect atherosclerotic plaques. The study is published in the October issue of the Journal ...

Oncology & Cancer

Blood test predicts success of neuroendocrine cancer therapy

Malignant neuroendocrine tumors (NETs) are relatively rare, notoriously difficult to treat, and associated with poor long-term survival. According to research presented at the 2016 Annual Meeting of the Society of Nuclear ...

Oncology & Cancer

Novel PET tracer narrows in on life-threatening blood clots

Fatal cardiac events are often preceded by abnormal blood clots, also called thrombosis. Scientists have now developed a molecular imaging technique that could save lives by revealing troublesome thrombi, according to a study ...

Neuroscience

Molecular imaging reveals marker of neurodegenerative disease

Brain researchers have been working for years on targeting a cellular process involved in neurodegeneration and cognitive dysfunction. A specialized molecular imaging agent does the job by binding to a transporter of the ...

page 10 from 27